Global Transcatheter Mitral Valve Replacement (TMVR) Market Research Report 2022

Market Analysis and Insights: Global Transcatheter Mitral Valve Replacement (TMVR) Market
TMVR, also known as transcatheter mitral valve replacement is a way of replacing the mitral valve in the heart without the need for conventional open-heart surgery. TMVR transcatheter mitral valve replacement is a treatment for mitral valve stenosis (tight mitral valve) or mitral valve regurgitation (leaky mitral valve) or a mix of the two. TMVR transcatheter mitral valve replacement was developed initially as a method of replacing the mitral valve in patients considered too high risk for surgery but will likely replace mitral valve replacement surgery in the future as the technology improves and the outcomes are proved.
The global Transcatheter Mitral Valve Replacement (TMVR) market size is projected to reach US$ 6528.2 million by 2028, from US$ 1157.5 million in 2021, at a CAGR of 27.7% during 2022-2028.
The classification of Transcatheter Mitral Valve Replacement (TMVR) includes MitraClip, Edwards PASCAL and Edwards SAPIEN 3. The market share of MitraClip in 2019 reached up to over 96%.
United States and Europe are the largest consumption place, with a revenue market share nearly 96% in 2019. The rest of global market mostly was taken up by China and Japan, which totally occupied a market share of over 2%.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Transcatheter Mitral Valve Replacement (TMVR) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Transcatheter Mitral Valve Replacement (TMVR) market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Transcatheter Mitral Valve Replacement (TMVR) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Transcatheter Mitral Valve Replacement (TMVR) market.
Global Transcatheter Mitral Valve Replacement (TMVR) Scope and Market Size
Transcatheter Mitral Valve Replacement (TMVR) market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Transcatheter Mitral Valve Replacement (TMVR) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
MitraClip
Edwards PASCAL
Edwards SAPIEN 3
Segment by Application
Functional Mitral Regurgitation (FMR)
Degenerative Mitral Regurgitation (DMR)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott
Edwards Lifesciences
Medtronic
Boston Scientific
Micro Interventional Devices
Neovasc
LivaNova
HighLife SAS

Frequently Asked Questions